Iran war to delay pharma supply recovery
New Delhi: Pharmaceutical industry experts said that a sustained ceasefire in the Iran conflict may not lead to immediate improvements in exports and drug prices.They said supply chains disrupted by the conflict will take months to stabilise, and prices of active pharmaceutical ingredients (APIs)-the raw materials that go into medicines-are expected to soften only gradually.The pace of recovery hinges on how quickly trade corridors reopen and inventory buffers are rebuilt, they said.Also Read:'I...
Original Source
Read the full article at Economictimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.